AC Immune S.A.ACIUNASDAQ
Loading
Year-over-year free cash flow growth rate
| Period | Value |
|---|---|
| Q3 2025 | -15.20% |
| Q2 2025 | 16.72% |
| Q1 2025 | -428.17% |
| Q4 2024 | 140.83% |
| Q3 2024 | -119.62% |
| Q2 2024 | 9314.06% |
| Q1 2024 | 104.74% |
| Q4 2023 | -20.45% |
| Q3 2023 | 4.84% |
| Q2 2023 | 16.06% |
| Q1 2023 | 2.56% |
| Q4 2022 | -27.75% |
| Q3 2022 | 31.77% |
| Q2 2022 | 15.48% |
| Q1 2022 | -27.67% |
| Q4 2021 | -23.72% |
| Q3 2021 | 9.95% |
| Q2 2021 | 8.15% |
| Q1 2021 | 10.39% |
| Q4 2020 | -27.67% |
| Q3 2020 | -3.95% |
| Q2 2020 | -54.01% |
| Q1 2020 | 25.69% |
| Q4 2019 | -180.46% |
| Q3 2019 | 207.70% |
| Q2 2019 | -123.48% |
| Q1 2019 | 646.11% |
| Q4 2018 | -0.08% |
| Q3 2018 | -58.80% |
| Q2 2018 | 47.69% |
| Q1 2018 | -327.06% |
| Q4 2017 | 181.31% |
| Q3 2017 | 21.50% |
| Q2 2017 | 20.30% |
| Q1 2017 | -73.31% |
| Q4 2016 | -188.20% |
| Q3 2016 | 2016.06% |
| Q2 2016 | 104.89% |
| Q1 2016 | -41.49% |
| Q4 2015 | -116.67% |